The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus–1 and –2 antibodies
Open Access
- 1 February 2005
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 192 (2) , 483-488
- https://doi.org/10.1016/j.ajog.2004.09.134
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Neonatal Herpes Simplex InfectionClinical Microbiology Reviews, 2004
- Effect of Serologic Status and Cesarean Delivery on Transmission Rates of Herpes Simplex Virus From Mother to InfantJAMA, 2003
- Seroprevalence and Coinfection with Herpes Simplex Virus Type 1 and Type 2 in the United States, 1988–1994The Journal of Infectious Diseases, 2002
- Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus InfectionsPediatrics, 2001
- Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to WomenJAMA, 2001
- Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral sheddingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpesAmerican Journal of Obstetrics and Gynecology, 2000
- A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2New England Journal of Medicine, 1999
- The Acquisition of Herpes Simplex Virus during PregnancyNew England Journal of Medicine, 1997
- Neonatal Herpes Simplex Virus Infection in Relation to Asymptomatic Maternal Infection at the Time of LaborNew England Journal of Medicine, 1991